Mark Hasleton
Keine laufenden Positionen mehr
Profil
Mark Hasleton worked as a Senior Director-Global New Therapeutic Entities at Teva Pharmaceutical Industries Ltd.
from 2010 to 2018.
He also worked as a Manager-EMEA Business Operations at Bristol Myers Squibb Co. He then worked as a Vice President-Business Development at Oramed Pharmaceuticals, Inc. from 2018 to 2019.
Dr. Hasleton holds a doctorate from Imperial College London, a graduate degree from The University of Manchester, and an MBA from Imperial College Business School.
Ehemalige bekannte Positionen von Mark Hasleton
| Unternehmen | Position | Ende |
|---|---|---|
| ORAMED PHARMACEUTICALS INC. | Corporate Officer/Principal | 27.08.2019 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.01.2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Ausbildung von Mark Hasleton
| Imperial College London | Doctorate Degree |
| The University of Manchester | Graduate Degree |
| Imperial College Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ORAMED PHARMACEUTICALS INC. | Health Technology |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
